RT @adnanalkhouli: @kashishgoelmd Yes! 54% alive and well at 1 year after Mitral TEER in TVT registry https://t.co/MKnqmzB1Ep 36% alive and…
@kashishgoelmd Yes! 54% alive and well at 1 year after Mitral TEER in TVT registry https://t.co/MKnqmzB1Ep 36% alive and with >moderate improvement in health status at 2 years in COAPT https://t.co/0diqKi02CO
@venkmurthy @ADAlthousePhD @ShariqShamimMD @PKCath @aminorex @CMichaelGibson @DrMarthaGulati @EM_RESUS @smithECGBlog @IAmDrIbrahim @ErinMichos @GreggWStone @CardioIAN @MKIttlesonMD @purviparwani And it would come out looking something like this... https://
New2Trip: Health Status After Transcatheter Mitral-Valve Repair in Heart Failure & Secondary Mitral Regurgitation: COAPT Trial https://t.co/q9k2HjU8oI
New2Trip: Health Status After Transcatheter Mitral-Valve Repair in Heart Failure & Secondary Mitral Regurgitation: COAPT Trial https://t.co/q9k2HjU8oI
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: In the #COAPT trial, #MitraClip resulted in substantial health status improvement compared with standard care. https://t.…
RT @JACCJournals: In the #COAPT trial, #MitraClip resulted in substantial health status improvement compared with standard care. https://t.…
RT @JACCJournals: In the #COAPT trial, #MitraClip resulted in substantial health status improvement compared with standard care. https://t.…
RT @JACCJournals: In the #COAPT trial, #MitraClip resulted in substantial health status improvement compared with standard care. https://t.…
RT @JACCJournals: In the #COAPT trial, #MitraClip resulted in substantial health status improvement compared with standard care. https://t.…
In the #COAPT trial, #MitraClip resulted in substantial health status improvement compared with standard care. https://t.co/udIkPD2mfr #JACC https://t.co/VAHsvAWts3
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
RT @JACCJournals: What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraCl…
What are the health status outcomes of #heartfailure patients with significant mitral regurgitation treated with #MitraClip? https://t.co/A7WdwDBHkq #JACC #COAPT https://t.co/k4MhSv6fwU
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @lamelaspablo: #WeeklyCardioReview #COAPT subanalysis in health status. #MitraClip superior vs OMT, NNT =5 to have 1 more patient alive…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
RT @JACCJournals: Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip r…
Among #heartfailure and significant secondary #vhdMR patients receiving maximally-tolerated medical therapy, #MitraClip resulted in improved health status compared with medical therapy alone. https://t.co/aNMykVH4Ip #JACC https://t.co/1s9TJDsYbN
RT @lamelaspablo: #WeeklyCardioReview #COAPT subanalysis in health status. #MitraClip superior vs OMT, NNT =5 to have 1 more patient alive…
RT @lamelaspablo: #WeeklyCardioReview #COAPT subanalysis in health status. #MitraClip superior vs OMT, NNT =5 to have 1 more patient alive…
RT @lamelaspablo: #WeeklyCardioReview #COAPT subanalysis in health status. #MitraClip superior vs OMT, NNT =5 to have 1 more patient alive…
#WeeklyCardioReview #COAPT subanalysis in health status. #MitraClip superior vs OMT, NNT =5 to have 1 more patient alive and with mod-large improvement in symptoms at @JACCJournals by @arnoldgehrke @GreggWStone @djc795 https://t.co/ckMvRCY3ly @AbbottCardio
Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation https://t.co/KPCTwoW7v7
RT @MidAmericaHeart: Great work by @arnoldgehrke and the quality outcomes group @MidAmericaHeart @saintlukeskc https://t.co/iZ9jVzJMm7
RT @djc795: Great work by @arnoldgehrke and the MAHI Health Economics Research group, examining the detailed QOL benefits of #MitraClip vs…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @JACCJournals: Dr. Blase Carabello challenges Dr. Suzanne Arnold: Which patients shouldn’t be treated with #MitraClip based on quality o…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @JACCJournals: Dr. Blase Carabello challenges Dr. Suzanne Arnold: Which patients shouldn’t be treated with #MitraClip based on quality o…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
RT @ValleAlfonso: Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardi…
Visual Abstract #COAPT: QoL After TMVR in HF and Secondary MR #ACC19 📎 https://t.co/uXyeYCqHrn vía @JACCJournals @secardiologia https://t.co/8308DAXVF9
RT @JACCJournals: Dr. Blase Carabello challenges Dr. Suzanne Arnold: Which patients shouldn’t be treated with #MitraClip based on quality o…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @JACCJournals: Dr. Blase Carabello challenges Dr. Suzanne Arnold: Which patients shouldn’t be treated with #MitraClip based on quality o…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @JACCJournals: Dr. Blase Carabello challenges Dr. Suzanne Arnold: Which patients shouldn’t be treated with #MitraClip based on quality o…
Dr. Blase Carabello challenges Dr. Suzanne Arnold: Which patients shouldn’t be treated with #MitraClip based on quality of life outcomes. Read full #COAPT study in #JACC: https://t.co/lpIZgyfn6Y @MidAmericaHeart https://t.co/NUttvs4Nfe
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation | JACC: Journal of the American College of Cardiology @djc795 @arnoldgehrke very nicely done! https://t.co/LBfkvfAOWk
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @MidAmericaHeart: Great work by @arnoldgehrke and the quality outcomes group @MidAmericaHeart @saintlukeskc https://t.co/iZ9jVzJMm7
RT @MidAmericaHeart: Great work by @arnoldgehrke and the quality outcomes group @MidAmericaHeart @saintlukeskc https://t.co/iZ9jVzJMm7
Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation https://t.co/tYGnYufcCP
RT @MidAmericaHeart: Great work by @arnoldgehrke and the quality outcomes group @MidAmericaHeart @saintlukeskc https://t.co/iZ9jVzJMm7
Great work by @arnoldgehrke and the quality outcomes group @MidAmericaHeart @saintlukeskc
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation COAPT Trial @JACCJournals @secardiologia https://t.co/X6yBbBVZLT https://t.co/cNKKjdEwwa
Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation https://t.co/Gc0d3YfAIE
RT @arnoldgehrke: TMVr with MitraClip rapidly improves symptoms, functional status, and QOL for patients with symptomatic HF and 3+ or 4+ s…
Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation https://t.co/IAu0cnxyJL Great work @djc795
COAPT incluyó 614 pac con IC mod a sev y reg mitral sev secundaria a disfunción ventricular y tto óptimo , aleatorizados a reparación mitral percútanea (mitraclip) más tto o solo tto , demostrando disminución del número de hospitalizaciones a 24m #SVC_AC
Great work @arnoldgehrke #MitraClip #ACC19 #ACCIC #ACCFIT #ACCEarlyCareer
Patients with symptomatic HF and 3+ / 4+ secondary MR on maximally-tolerated medical therapy, edge-to-edge TMVr resulted in substantial early and sustained health status improvement compared with medical therapy alone. https://t.co/DquoEdWh9A